The observations suggest that the tumor suppressor gene CDKN2 is a potential candidate for ge ne replacement therapy of NSCLC.
结果表明肿瘤抑制基因CDKN2可望成为NSCLC基因替代治疗的候选基因。
2
Its potential homologue MIM-B is also thought to code a putative tumor metastasis suppressor protein.
MIM可能的同系物mim - B同样被认为编码一种假定的转移抑制蛋白。
3
With the new technique, it is possible to identify potential tumour-suppressor genes from among the approximately 25,000 human genes and accelerate research significantly.